Song and colleagues showed that Hsp90α, but not Hsp90β, stabilized MMP2 and protected it from degradation in tumour cells in an ATP-independent manner and was mediated by the middle domain of Hsp90α binding to the C-terminal hemopexin domain of MMP2 [73]. The gene discussed is MMP2; the disease is neoplasm.